Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig D Shriver

Showing results (271-280 of 293) with videos related to

Pageof 30
Sort By:
Journal of Surgical Oncology|December 1, 2007
Electrical impedance scanning as a new breast cancer risk stratification tool for young womenAlexander Stojadinovic, Aviram Nissan, Craig D Shriver, et al.
Biopreservation and Biobanking|May 25, 2026
The Development of Tools to Investigate Potential Sources of Sample Misidentification Within a Biorepository: Case StudiesKatie Miller, Heather L Blackburn, Susan M Shuss, et al.
Cancers|March 13, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United StatesCollin A Sitler, Chunqiao Tian, Chad A Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failureAmy R Peck, Agnieszka K Witkiewicz, Chengbao Liu, et al.
Breast Cancer Research : BCR|October 6, 2012
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomesAmy R Peck, Agnieszka K Witkiewicz, Chengbao Liu, et al.
Clinical Pharmacology and Therapeutics|March 7, 2019
From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer PatientsJerry S H Lee, Kathleen M Darcy, Hai Hu, et al.
JAMA Oncology|May 5, 2017
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome AtlasDezheng Huo, Hai Hu, Suhn K Rhie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 SignalingThai H Tran, Fransiscus E Utama, Takahiro Sato, et al.
JAMA Network Open|April 17, 2023
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine CancerCalen W Kucera, Chunqiao Tian, Christopher M Tarney, et al.
Cancer|June 28, 2017
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patientsNicholas W Bateman, Elizabeth A Dubil, Guisong Wang, et al.
Pageof 30

Showing results (271-280 of 293) with videos related to

Sort By:
Pageof 30
Journal of Surgical Oncology|December 1, 2007
Electrical impedance scanning as a new breast cancer risk stratification tool for young womenAlexander Stojadinovic, Aviram Nissan, Craig D Shriver, et al.
Biopreservation and Biobanking|May 25, 2026
The Development of Tools to Investigate Potential Sources of Sample Misidentification Within a Biorepository: Case StudiesKatie Miller, Heather L Blackburn, Susan M Shuss, et al.
Cancers|March 13, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United StatesCollin A Sitler, Chunqiao Tian, Chad A Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failureAmy R Peck, Agnieszka K Witkiewicz, Chengbao Liu, et al.
Breast Cancer Research : BCR|October 6, 2012
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomesAmy R Peck, Agnieszka K Witkiewicz, Chengbao Liu, et al.
Clinical Pharmacology and Therapeutics|March 7, 2019
From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer PatientsJerry S H Lee, Kathleen M Darcy, Hai Hu, et al.
JAMA Oncology|May 5, 2017
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome AtlasDezheng Huo, Hai Hu, Suhn K Rhie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2018
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 SignalingThai H Tran, Fransiscus E Utama, Takahiro Sato, et al.
JAMA Network Open|April 17, 2023
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine CancerCalen W Kucera, Chunqiao Tian, Christopher M Tarney, et al.
Cancer|June 28, 2017
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patientsNicholas W Bateman, Elizabeth A Dubil, Guisong Wang, et al.
Pageof 30